These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 8581064)

  • 1. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ
    Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
    Kang YJ
    Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: the effect of glutamate supplementation.
    Kang YJ; Feng Y; Hatcher EL
    J Cell Physiol; 1994 Dec; 161(3):589-96. PubMed ID: 7962140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ
    Toxicology; 1994 Mar; 88(1-3):177-89. PubMed ID: 8160199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glutathione levels in quiescent, serum-stimulated NRK-49F cells are associated not with a response to growth factors but with nutrient repletion.
    Kang YJ; Enger MD
    J Cell Physiol; 1991 Aug; 148(2):197-201. PubMed ID: 1679059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil cytotoxicity in human colon HT-29 cells with moderately increased or decreased cellular glutathione level.
    Chen MF; Chen LT; Boyce HW
    Anticancer Res; 1995; 15(1):163-7. PubMed ID: 7733628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
    Messina JP; Lawrence DA
    J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
    Smyth MJ
    J Immunol; 1991 Mar; 146(6):1921-7. PubMed ID: 2005386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of cytostatic effect of recombinant human lymphotoxin and involvement of glutathione redox cycle.
    Matsunaga K; Mashiba H
    Eur Cytokine Netw; 1992; 3(3):307-11. PubMed ID: 1498261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Xia H; Pinto T; Hu X; Benson PJ; Zaren HA; Gupta V; Singh S
    Cancer Res; 1996 Aug; 56(15):3495-8. PubMed ID: 8758917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glutathione in the aerobic radioresponse. I. Sensitization and recovery in the absence of intracellular glutathione.
    Clark EP; Epp ER; Morse-Gaudio M; Biaglow JE
    Radiat Res; 1986 Dec; 108(3):238-50. PubMed ID: 3797633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
    Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL; Wedner HJ
    J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
    Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.